Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice
- PMID: 27413021
- DOI: 10.1042/CS20160183
Interleukin-18 deficiency protects against renal interstitial fibrosis in aldosterone/salt-treated mice
Abstract
Interleukin (IL)-18 is a member of the IL-1 family of cytokines and was described originally as an interferon γ-inducing factor. Aldosterone plays a central role in the regulation of sodium and potassium homoeostasis by binding to the mineralocorticoid receptor and contributes to kidney and cardiovascular damage. Aldosterone has been reported to induce IL-18, resulting in cardiac fibrosis with induced IL-18-mediated osteopontin (OPN). We therefore hypothesized that aldosterone-induced renal fibrosis via OPN may be mediated by IL-18. To verify this hypothesis, we compared mice deficient in IL-18 and wild-type (WT) mice in a model of aldosterone/salt-induced hypertension. IL-18(-/-) and C57BL/6 WT mice were used for the uninephrectomized aldosterone/salt hypertensive model, whereas NRK-52E cells (rat kidney epithelial cells) were used in an in vitro model. In the present in vivo study, IL-18 protein expression was localized in medullary tubules in the WT mice, whereas in aldosterone-infused WT mice this expression was up-regulated markedly in the proximal tubules, especially in injured and dilated tubules. This renal damage caused by aldosterone was attenuated significantly by IL-18 knockout with down-regulation of OPN expression. In the present in vitro study, aldosterone directly induced IL-18 gene expression in renal tubular epithelial cells in a concentration- and time-dependent manner. These effects were inhibited completely by spironolactone. IL-18 may be a key mediator of aldosterone-induced renal fibrosis by inducing OPN, thereby exacerbating renal interstitial fibrosis. Inhibition of IL-18 may therefore provide a potential target for therapeutic intervention aimed at preventing the progression of renal injury.
Keywords: aldosterone; interleukin-18; osteopontin; renal interstitial fibrosis.
© 2016 The Author(s). published by Portland Press Limited on behalf of the Biochemical Society.
Similar articles
-
Osteopontin deficiency protects against aldosterone-induced inflammation, oxidative stress, and interstitial fibrosis in the kidney.Am J Physiol Renal Physiol. 2011 Oct;301(4):F833-44. doi: 10.1152/ajprenal.00557.2010. Epub 2011 Jul 6. Am J Physiol Renal Physiol. 2011. PMID: 21734100
-
IL-18 (Interleukin-18) Produced by Renal Tubular Epithelial Cells Promotes Renal Inflammation and Injury During Deoxycorticosterone/Salt-Induced Hypertension in Mice.Hypertension. 2021 Nov;78(5):1296-1309. doi: 10.1161/HYPERTENSIONAHA.120.16437. Epub 2021 Sep 7. Hypertension. 2021. PMID: 34488433
-
Aldosterone/salt induces renal inflammation and fibrosis in hypertensive rats.Kidney Int. 2003 May;63(5):1791-800. doi: 10.1046/j.1523-1755.2003.00929.x. Kidney Int. 2003. PMID: 12675855
-
Role of Aldosterone in Renal Fibrosis.Adv Exp Med Biol. 2019;1165:325-346. doi: 10.1007/978-981-13-8871-2_15. Adv Exp Med Biol. 2019. PMID: 31399972 Review.
-
Mineralocorticoids and cardiac fibrosis: the decade in review.Clin Exp Pharmacol Physiol. 2001 Dec;28(12):1002-6. doi: 10.1046/j.1440-1681.2001.03586.x. Clin Exp Pharmacol Physiol. 2001. PMID: 11903303 Review.
Cited by
-
Inflammatory Cytokines as Uremic Toxins: "Ni Son Todos Los Que Estan, Ni Estan Todos Los Que Son".Toxins (Basel). 2017 Mar 23;9(4):114. doi: 10.3390/toxins9040114. Toxins (Basel). 2017. PMID: 28333114 Free PMC article. Review.
-
Osteopontin - The stirring multifunctional regulatory factor in multisystem aging.Front Endocrinol (Lausanne). 2022 Dec 22;13:1014853. doi: 10.3389/fendo.2022.1014853. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36619570 Free PMC article. Review.
-
Mineralocorticoid Receptor Signaling as a Therapeutic Target for Renal and Cardiac Fibrosis.Front Pharmacol. 2017 May 29;8:313. doi: 10.3389/fphar.2017.00313. eCollection 2017. Front Pharmacol. 2017. PMID: 28611666 Free PMC article. Review.
-
Micheliolide Attenuates Lipopolysaccharide-Induced Inflammation by Modulating the mROS/NF-κB/NLRP3 Axis in Renal Tubular Epithelial Cells.Mediators Inflamm. 2020 Aug 17;2020:3934769. doi: 10.1155/2020/3934769. eCollection 2020. Mediators Inflamm. 2020. PMID: 32879619 Free PMC article.
-
Physiological and molecular effects of interleukin-18 administration on the mouse kidney.J Transl Med. 2018 Mar 7;16(1):51. doi: 10.1186/s12967-018-1426-6. J Transl Med. 2018. PMID: 29514661 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous